Geode Capital Management, LLC Dare Bioscience, Inc. Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$0.28 - $0.61 $4,830 - $10,524	17,253 Added 1.74%	1,006,561 $342,000
Q1 2024 May 13, 2024	BUY	$0.31 - $0.57 $5,638 - $10,367	18,189 Added 1.87%	989,308 $484,000
Q4 2023 Feb 13, 2024	BUY	$0.29 - $0.53 $44,410 - $81,164	153,140 Added 18.72%	971,119 $301,000
Q3 2023 Nov 13, 2023	BUY	$0.46 - $0.91 $295 - $585	643 Added 0.08%	817,979 $376,000
Q4 2022 Feb 13, 2023	SELL	$0.82 - $12.6 $1,547 - $23,776	-1,887 Reduced 0.23%	817,336 $678,000
Q3 2022 Nov 14, 2022	BUY	$1.04 - $12.48 $107,838 - $1.29 Million	103,691 Added 14.49%	819,223 $819,000
Q2 2022 Aug 12, 2022	BUY	$0.94 - $1.76 $15,979 - $29,918	16,999 Added 2.43%	715,532 $880,000
Q1 2022 May 13, 2022	BUY	$1.42 - $2.09 $306,599 - $451,262	215,915 Added 44.74%	698,533 $1.04 Million
Q4 2021 Feb 11, 2022	SELL	$1.42 - $2.13 $119,379 - $179,069	-84,070 Reduced 14.84%	482,618 $965,000
Q3 2021 Nov 12, 2021	BUY	$1.42 - $2.0 $364,045 - $512,740	256,370 Added 82.62%	566,688 $946,000
Q2 2021 Aug 13, 2021	BUY	$1.21 - $1.89 $61,800 - $96,531	51,075 Added 19.7%	310,318 $586,000
Q1 2021 May 12, 2021	BUY	$1.31 - $3.0 $63,143 - $144,603	48,201 Added 22.84%	259,243 $438,000
Q4 2020 Feb 12, 2021	BUY	$0.96 - $1.51 $117,910 - $185,462	122,823 Added 139.23%	211,042 $282,000
Q1 2020 May 14, 2020	SELL	$0.79 - $1.7 $44,109 - $94,919	-55,835 Reduced 38.76%	88,219 $74,000
Q2 2019 Aug 14, 2019	BUY	$0.79 - $1.66 $30,481 - $64,049	38,584 Added 36.58%	144,054 $122,000
Q4 2018 Feb 13, 2019	BUY	$0.63 - $1.12 $29,717 - $52,830	47,170 Added 80.91%	105,470 $73,000
Q2 2018 Aug 14, 2018	BUY	$0.76 - $1.48 $44,308 - $86,284	58,300 New	58,300 $68,000

Others Institutions Holding DARE

# of Institutions

Shares Held

267K

Call Options Held

Put Options Held

View Full List

About Dare Bioscience, Inc.

Ticker DARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,820,896
Market Cap $270M
Description
Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States. It develops therapies in the areas of contraception, fertility, and sexual and vaginal health. The company's product includes XACIATO, a single-dose vaginal gel prescription pr...

More about DARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account